| The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases N Chalasani, Z Younossi, JE Lavine, M Charlton, K Cusi, M Rinella, ... Hepatology 67 (1), 328-357, 2018 | 6425 | 2018 |
| The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of … N Chalasani, Z Younossi, JE Lavine, AM Diehl, EM Brunt, K Cusi, ... Hepatology 55 (6), 2005-2023, 2012 | 5016 | 2012 |
| Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis AJ Sanyal, N Chalasani, KV Kowdley, A McCullough, AM Diehl, NM Bass, ... New England Journal of Medicine 362 (18), 1675-1685, 2010 | 3709 | 2010 |
| Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial BA Neuschwander-Tetri, R Loomba, AJ Sanyal, JE Lavine, ML Van Natta, ... The Lancet 385 (9972), 956-965, 2015 | 2416 | 2015 |
| The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of … N Chalasani, Z Younossi, JE Lavine, AM Diehl, EM Brunt, K Cusi, ... Gastroenterology 142 (7), 1592-1609, 2012 | 2105 | 2012 |
| Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial JE Lavine, JB Schwimmer, ML Van Natta, JP Molleston, KF Murray, ... Jama 305 (16), 1659-1668, 2011 | 1276 | 2011 |
| ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury NP Chalasani, PH Hayashi, HL Bonkovsky, VJ Navarro, WM Lee, ... Official journal of the American College of Gastroenterology| ACG 109 (7 …, 2014 | 1230* | 2014 |
| Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States N Chalasani, RJ Fontana, HL Bonkovsky, PB Watkins, T Davern, ... Gastroenterology 135 (6), 1924-1934. e4, 2008 | 1142 | 2008 |
| Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management R Vuppalanchi, N Chalasani Hepatology 49 (1), 306-317, 2009 | 892 | 2009 |
| Endpoints and clinical trial design for nonalcoholic steatohepatitis AJ Sanyal, EM Brunt, DE Kleiner, KV Kowdley, N Chalasani, JE Lavine, ... Hepatology 54 (1), 344-353, 2011 | 843 | 2011 |
| Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, ... Gastroenterology 148 (7), 1340-1352. e7, 2015 | 817 | 2015 |
| Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study E Vilar-Gomez, L Calzadilla-Bertot, VWS Wong, M Castellanos, ... Gastroenterology 155 (2), 443-457. e17, 2018 | 660 | 2018 |
| Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity N Chalasani, H Aljadhey, J Kesterson, MD Murray, SD Hall Gastroenterology 126 (5), 1287-1292, 2004 | 621 | 2004 |
| Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease KV Kowdley, P Belt, LA Wilson, MM Yeh, BA Neuschwander‐Tetri, ... Hepatology 55 (1), 77-85, 2012 | 617 | 2012 |
| Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease BA Neuschwander‐Tetri, JM Clark, NM Bass, ML Van Natta, ... Hepatology 52 (3), 913-924, 2010 | 587 | 2010 |
| Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers E Vilar-Gomez, N Chalasani Journal of hepatology 68 (2), 305-315, 2018 | 581 | 2018 |
| Predictors of inadequate bowel preparation for colonoscopy RM Ness, R Manam, H Hoen, N Chalasani Official journal of the American College of Gastroenterology| ACG 96 (6 …, 2001 | 564 | 2001 |
| An assessment of statin safety by hepatologists DE Cohen, FA Anania, N Chalasani The American journal of cardiology 97 (8), S77-S81, 2006 | 542 | 2006 |
| Drug-induced liver injury RJ Andrade, N Chalasani, ES Björnsson, A Suzuki, GA Kullak-Ublick, ... Nature Reviews Disease Primers 5 (1), 58, 2019 | 528 | 2019 |
| Prospective study of outcomes in adults with nonalcoholic fatty liver disease AJ Sanyal, ML Van Natta, J Clark, BA Neuschwander-Tetri, AM Diehl, ... New England Journal of Medicine 385 (17), 1559-1569, 2021 | 527 | 2021 |
